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Abstract
Objective: Patient involvement into medical decisions as conceived in the shared decision making method (SDM) is
essential in evidence based medicine. However, it is not conclusively evident how best to define, realize and evaluate
involvement to enable patients making informed choices. We aimed at investigating the ability of four measures to indicate
patient involvement. While use and reporting of these instruments might imply wide overlap regarding the addressed
constructs this assumption seems questionable with respect to the diversity of the perspectives from which the
assessments are administered.
Methods: The study investigated a nested cohort (N=79) of a randomized trial evaluating a patient decision aid on
immunotherapy for multiple sclerosis. Convergent validities were calculated between observer ratings of videotaped
physician-patient consultations (OPTION) and patients’ perceptions of the communication (Shared Decision Making
Questionnaire, Control Preference Scale & Decisional Conflict Scale).
Results: OPTION reliability was high to excellent. Communication performance was low according to OPTION and high
according to the three patient administered measures. No correlations were found between observer and patient judges,
neither for means nor for single items. Patient report measures showed some moderate correlations.
Conclusion: Existing SDM measures do not refer to a single construct. A gold standard is missing to decide whether any of
these measures has the potential to indicate patient involvement.
Practice Implications: Pronounced heterogeneity of the underpinning constructs implies difficulties regarding the
interpretation of existing evidence on the efficacy of SDM. Consideration of communication theory and basic definitions of
SDM would recommend an inter-subjective focus of measurement.
Trial Registration: Controlled-Trials.com ISRCTN25267500.
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Introduction
The aim of evidence based medicine (EBM) is to provide the
means by which current best evidence from research can be
applied to medical decision making [1]. Since evidence alone does
not make decisions [2], such means are not exhausted by
generation, synthesis and appraisal of research evidence. They
rather imply providing evidence to patients in a way that allows
them to make an informed choice [2]. The latter has been
conceived as the ‘shared decision making’ method (SDM), a
communication strategy to involve patients into the process of
making their medical decisions.
Following this concept, patient involvement implies a two way
exchange of information between doctor and patient where
options are made explicit, appraisal of current best evidence is
negotiated, and patient desires are elicited [3]. This style of
communication contrasts the traditional benevolent paternalism
where patients are assigned to a passive role in the decision making
process [3]. Emphasizing its relevance for the quality of
healthcare, SDM can be seen as a key method in realizing the
underpinning goals of EBM. Apart from ethical guidelines [4] and
patients’ pronounced role preferences for more participation in
decision making [5], this view is supported by efficacy studies.
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to improve decision quality by enhancing knowledge, patient
satisfaction with the decision making process and realistic
expectations, or by decreasing fears and decisional conflict [6].
Other studies evaluating SDM interventions have found no
effects on communication, patient satisfaction or on health status
[6–9]. Theory is lacking to predict conditions under which SDM
can yield desired effects [10]. Apart from this, evidence on efficacy
of SDM can just be considered meaningful to the extent to which
the communication measurement is valid. However, too little
attention has been given to the issue of SDM measurement [11–
14].
While most instruments address associated dimensions such as
patients’ decision making needs, decision support, satisfaction or
the feeling of being informed, few instruments address aspects of
the communicative process. These vary with regard to their level
of validation and to the perspective from which SDM is assessed:
the observer’s, the physician’s or the patient’s perspective. Most
feasible to administer, a few patient questionnaires exist to assess
perceived quality of the decision making process in terms of either
the feeling of being informed, supported and taken serious with
one’s individual preferences (Shared Decision Making Question-
naire, SDMQ, Perceived Involvement in Care Scale, PICS and
Decision Conflict Scale DCS [11]), or in terms of the social role
model between patient and physician in the consultation (Control
Preference Scale CPS [11]). Another promising method is an
observation based rating scale (OPTION=Observing Patient
Involvement [15]), providing criteria to appraise the physician’s
behavioural efforts to involve the patient. OPTION has already
been used in many countries and settings [16–19].
All these measurements approach patient involvement using a
unilateral perspective as a proxy for SDM. Although proofs of
validity for these instruments in some regard have been published
[14], e.g. showing the OPTION scale sensitive to physicians’
communication behaviour [15], their validity with regard to
patient involvement as an interpersonal process has not yet been
investigated. It is, however, evident from communication theory
that a two way exchange of information and the shared appraisal
and negotiation of a decision making process is a dynamic
interpersonal process not operable from any unilateral perspective
[20].
Our study therefore aimed to examine the OPTION scale’s
ability to indicate patient involvement in physician patient
consultations as perceived from the patient perspective. Assuming
that (as a proof of validity) SDM measures administered from
varying viewpoints should correspond, we applied OPTION and
three measures assessing SDM from the patients’ perspectives to
the same pool of consultations. By yielding empirical evidence on
the degree of interrelatedness of commonly used approaches to
SDM this study also contributes to the debate on conceptual issues
and underpinning assumptions which are reflected by these
measurement approaches [20].
Methods
Ethics statement
The study protocol was approved by the ethics committee of the
Hamburg Chamber of Physicians, and all participants gave
written informed consent for record, analyses and publication of
their data collected within this study.
Umbrella study
We studied a nested cohort of a randomized controlled trial
(RCT) [8] evaluating the effectiveness of a patient decision aid
developed to support people with multiple sclerosis (MS) in
deciding on immunotherapy (Figure 1) referred to as umbrella
study. Overall, 297 patients were included in this umbrella study,
recruited mainly through press advertisements published through-
out Germany, but also directly at the main study centre in
Hamburg. To obtain deeper insights into the communication we
asked all patients recruited at the Hamburg study centre to agree
to video recording of their consultations with the physician. These
records served as sample of communication behaviour for the
present study. The development of the decision aid and the results
of its effects have been reported elsewhere [8,21].
Content of the decision and context
Accompanied by the physician on duty, participants were either
considering whether to start immunotherapy or reconsidering
their current immunotherapy. Depending on the course and stage
of the disease, different kinds of immunotherapy are available.
Accordingly, the number of options varied from case to case as
well as the probabilities of benefit. Neither further disease course
nor chance of benefit can be predicted in an individual case.
Moreover, long-time effectiveness of immunotherapy is a matter of
debate [22]. Since patients have to weigh up uncertain benefit and
considerable side effects, this decision is highly appropriate for a
shared decision making process [23]. As an inclusion criterion of
the umbrella trial, all patients had an actual decision to make and,
as a consequence of the design of the umbrella trial, the decision
was made within these consultations.
Measurement
The umbrella study collected data at 4 measurement points:
baseline (T0), after intervention (T1), directly after consultation
(T2), and about 5 months after consultation (T3) [8]. Beyond the
demographic and disease related data, treatment choice and
different scores evaluating the communication were recorded. The
nested cohort study is based on four different judgements of
patient involvement: one administered by objective observers
based on video documents; three administered by the patients, two
of these directly after the consultation (T2); and one six months
after randomisation (T3).
OPTION scale
The OPTION scale [16] is typically administered by an
observer watching the physician-patient conversation, and then
scoring the physician’s offers to involve the patient on a five point
Likert scale (0=‘not observed’; 4=‘executed to a high standard’)
(Table 1). In a chronological order, 12 items cover the decision
making process beginning at a precise statement referring to the
subject of the particular decision and ending in the decision itself
and the follow up statements [16]. The analyses conducted in this
study were based on video documents (T2). All consultations were
analysed by JK, who had been trained to use the coding manual
by the scale’s principal author. Videos were analysed in random
order, and the rater was blind to any other study data of the
patients. Rater training was simultaneously given to an advanced
student (GB). This involved each judgement being explicitly
deduced and comprehensively explained on the basis of the
manual for trainees. This proceeding was intended to maximise
reliability of the observer data. Independently, the trainee
recorded her own ratings referring to each video. In cases of
doubt or disagreement, the video was analysed again. In addition,
a record was made of problems relating to the applicability of the
rating instrument, such as obvious limitations of distinctiveness or
exhaustivity.
Study on Interrelatedness of SDM Measures
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The SDM-Q was used to assess patients’ view on the con-
sultations. The questionnaire follows the same taxonomy of
decision making steps as the OPTION scale and was developed
to show the extent to which patients felt they were involved in the
process. In its revised form, SDM-Q has 11 items scoring from 0
to 3 on a 4 point Likert scale [24–25]. Patients received the
questionnaire by mail for self-administration after the consultation
(T2).
Control Preference Scale (CPS)
The CPS [26] presents subjects with a choice of five alternative
decisional roles and requires them to identify the one that best
describes their preferred position. In the present study CPSpost was
used, which is supposed to evaluate the role position after a
consultation. CPSpost was sent to patients as a multiple choice
questionnaire and assessed at T2 during a telephone interview.
According to Degner [26], the 5 descriptions of social role
distributions in the physician-patient-interaction were: 1: ‘‘I made
my decision alone’’, 2: ‘‘I made my decision alone considering
what my doctor said’’, 3: ‘‘I shared the decision with my doctor’’,
4: ‘‘My doctor decided considering my preferences’’, 5: ‘‘My
doctor made the decision’’. The CPSpost also included the answer
‘‘the decision was deferred’’.
Decisional Conflict Scale (DCS)
The DCS [27] was presented at T3 in a form slightly adapted to
the specific decision by exchange of abstract terms by terms
referring to the particular decision on immunotherapy. The 16
items scoring from 0 to 4 on a 5 point Likert scale includes five
subscales: certainty (3 items), information (3 items), values (3),
support (3), and quality of the decision (4 items). The latter and the
scale’s meanscorecanbe understood asa globalrating ofthedegree
the patient feels comfortable with the decision. Moreover, since
most items address issues evaluating the process rather than the
result of making a decision and these items cover the characters of
an ideal SDM, many authors used the DCS as a measure for quality
of the decision making process in terms of SDM.
Hypotheses
Considering the raters’ intensive training and previous experi-
ence and the homogeneity of the sample, we expected to find high
levels of inter- and intra-rater reliability when applying the
OPTION scale. The four instruments included in this study are all
Figure 1. Flow of participants through umbrella trial and nested cohort trial.
doi:10.1371/journal.pone.0026255.g001
Study on Interrelatedness of SDM Measures
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26255approaching patient involvement via a proxy by accessing a single
aspect theoretically associated with the construct, such as the
physician’s skills (OPTION), the patient’s perception or evaluation
of the decision (DCS, SDM-Q), and the realized role model
(CPSpost). While being aware of the widespread use of these
instruments to measure SDM, we attributed this habit to the lack
of appropriate measures of the construct rather than to their
factual ability to capture the same construct. Therefore, and based
on theoretical considerations [20], we expected to find OPTION,
SDM-Q, CPSpost, and DCS at most moderately interrelated. We
expected, however, higher correlations between single item pairs
of OPTION and SDM-Q addressing identical content.
Methods of analysis
After training with 50 consultations, inter-rater-reliability (IRR)
was calculated based on the remaining subsample of videos using
Spearman correlation coefficients. Additionally, 15 randomly
selected videos were rated again by one of the raters (JK) after one
year to ascertain intra-rater-reliability. CPS responses were lumped
for analysis reducing the number of options from five to three [8].
OPTION scores were transformed to a 0–100 scale as recom-
mended [16]. To explore the relationships between SDM measures
mean scores from OPTION, SDM-Q and DCS were correlated
pair-wise (Spearman). In our nested cohort, global correlations (in
thepooledsample)couldpotentiallyderivefromlocallyuncorrelated
data (for each physician and for group allocation) and vice versa.
Therefore, local correlations within each physician contributing
enough consultations and for each group were calculated. Three
patient groups defined by CPS response were compared regarding
potentially varying communication indices (OPTION, DCS and
SDM-Q) using Kruskal-Wallis test. Single pairs of OPTION and
SDM-Q items with equal or similar content were identified and
Spearman correlations were calculated within these pairs.
Results
During the umbrella trial, 79 (of 297) participants were recruited
by the Hamburg study centre. All participants consented to video
recording. 76 of the 79 videos were useable (three could not be
analysed for technical reasons). Four physicians were involved in
consultations with this subsample. The subsample was comparable
to the total sample with regard to demographic and disease related
variables [8]. Inter-rater reliability for the OPTION scale was high
(rho=.83) and intra-rater-reliability was very high (rho=.94)
calculated based on 26 videos (Table 1). According to OPTION,
the physicians’ performance was on the level of ‘‘making attempts to
involve the patient’’ (mean=30) (Table 1). The physicians showed
some differences in their mean scores (27.5 to 37.5) which were
significant (p=.009) due to low intra-group variance (SD=10). In
contrast, patients’ reports of perceived involvement were quite
positive (SDM-Q mean=2.4, SD=.56). These values did not differ
from the values obtained from the total sample.
The investigation of the relationships between SDM measures
revealed extensive incongruence between the four instruments
(Figure 2, 3). Virtually no correlation was found between OPTION
mean score and SDM-Q mean score (rho=2.01,p=.93), between
OPTION mean score, DCS mean score (rho=.05,p=.66), and the
mean scores of the five DCS subscales (certainty, information,
validation, support, quality: rho=.00 to .13,p=.99 to .28).
Moreover, Kruskal-Wallis test revealt no relations between the
self-reported role position within the dyad (CPSpost) and SDM as
measured by OPTION (p=.87) or decisional conflict (p=.23).
Accordingly, correlations within each physician and within each
condition of the umbrella study (decision aid vs. standard
information) were comparably low (Figure 2). However, perception
of a more autonomous role (CPSpost) was associated with more
involvement as reported in SDM-Q (Kruskal-Wallis test, p,.001 in
the total sample). Accordingly, SDM-Q was moderately correlated
with DCS (rho=.38,p,.001). Even four (SDM-Q & OPTION)
itempairswithidenticalcontentyieldeduncorrelateddata(Table2).
This also holds for analysis of physician-based clusters and within
each condition.
Discussion
Principal findings
This paper presents one of the few studies applying multiple
SDM measurement techniques to a specific consultation [19,
Table 1. Observed communication competences and reliability.
OPTION item Mean(SD) InterRR IntraRR
1) The clinician draws attention to an identified problem as one that requires a decision making process. 1.2(1.2) .92 .98
2) The clinician states that there is more than one way to deal with the identified problem (‘equipoise’). 0.8(1.0) .83 .93
3) The clinician assesses the patient’s preferred approach to receiving information to assist decision making
(e.g. discussion, reading printed material, assessing graphical data, using videotapes or other media).
0.05(0.3) 1 1
4) The clinician lists ‘options’, which can include the choice of ‘no action’. 0.7(0.9) .87 1
5) The clinician explains the pros and cons of options to the patient (taking ‘no action’ is an option). 1.5(0.9) .87 .90
6) The clinician explores the patient’s expectations (or ideas) about how the problem(s) are to be managed. 2.2(0.8) .73 .91
7) The clinician explores the patient’s concerns (fears) about how problem(s) are to be managed. 1.8(1.9) .76 .78
8) The clinician checks that the patient has understood the information. 0.1(0.5) 1 1
9) The clinician offers the patient explicit opportunities to ask questions during the decision making process. 1.4(0.7) .99 .90
10) The clinician elicits the patient’s preferred level of involvement in decision-making. 0.8(0.6) .50 .89
11) The clinician indicates the need for a decision making (or deferring) stage. 1.4(1.1) .83 1
12) The clinician indicates the need to review the decision (or deferment). 2.4(1.4) .67 .95
Mean 1.2(0.4) .83 .94
Item range 0–4: 0=skill not observed, 4=skill executed to a high standard; InterRR=inter-rater reliability, based on 26 consultations IntraRR =intra-rater reliability,
based on 15 consultations (Correlation coefficients are based on Spearman).
doi:10.1371/journal.pone.0026255.t001
Study on Interrelatedness of SDM Measures
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which their underpinning constructs are empirically congruent.
With regard to the clarity of our results, it can even be challenged
whether any of these measures has the ability to validly assess
SDM.
Our study found that observations of patient involvement in
decision making processes about immunotherapy as judged from
physicians’ behaviour using OPTION were completely unrelated
to the patients’ reports of being involved (SDM-Q), their level of
decision autonomy (CPSpost), and their evaluation of the decision
quality (DCS). The correlations between instruments focussing on
the patients’ perception of the communication were in part
significant but even these only moderately (CPSpost / SDM-Q and
DCS/ SDM-Q).
Limitations
These results were yielded based on data drawn from a
convenient sample in one of the study centres of the umbrella trial.
Due to this strategy and the limited number of involved physicians
all belonging to the same unit the communication material might
not be representative for other medical contexts, patient
populations or patient-physician dyads. As far we were able to
examine this, our results are robust with regard to potential biases
caused by different physicians or by properties of the instruments
used, such as reliability, variability or the considerable ceiling
effect. All correlations between CPS, DCS and SDM-Q remained
unchanged when calculated for the total sample of the umbrella
study. It may be argued that adjusting the alpha level due to
multiple testing of correlations would have been appropriate to
avoid identification of false positive correlations. However, as in
this study there were hardly any significant correlations,
adjustment would not have changed our main conclusions. As
shown by others [16–19], the OPTION scale turned out to be
applicable with high levels of reliability. During our work with the
instrument, we felt however increasingly critical of its ability to
capture the involvement taking place. The conceptual limitation to
assessment of physicians’ behaviour under some conditions leads
to some noteworthy paradoxes. Doctors allowing patients’ to
involve themselves actively by initiating SDM behaviour are
poorly evaluated for omitting the latter. Apart from this, we found
the OPTION scale’s selection of items incomplete and laying
higher emphasis on the doctor’s compared to the patient’s parts.
For instance, apart from the item assessing the physician’s efforts
to reassure the patients understanding (Item 8), we missed a
corresponding item assessing his/her understanding of the
patient’s point of view. Moreover, OPTION does not include
disclosure of the source of recommendations and information (e.g.
own experience, scientific evidence, own preferences e.g. due to a
conflict of interest), which is an important quality marker of
evidence based risk communication [32].
It can be challenged that our sample might not be represen-
tative for other decisional settings. The type of decision, however,
with regard to pronounced uncertainty within a chronic condition
seems paradigmatic for SDM and choices in health care in
general. Moreover, SDM can be meaningfully applied whenever a
decision between more than one option is to be made. We see no
reason why SDM measurements should work dependent on the
specific context or course of a decision. Results may not be
generalizable to dyads performing higher levels of patient
involvement than seen in this study, which, however, were quite
comparable to those reported from other studies [15,17–18]. Since
there was nevertheless enough variance in the OPTION scores to
reach excellent reliability indices, we would not call this poor
performance a floor effect. The delay between the record of DCS
and the other three measures limits their comparability. As DCS is
constructed rather as a measure of decision quality, it can be
questioned from a theoretical point of view to which degree the
DCS covers the same construct as OPTION, SDM-Q and
CPSpost. However, at least three scales, ‘feeling sufficiently
informed’, ‘having had opportunity to consider values and
preferences’, and ‘feeling supported by the doctor’ meet the core
issues addressed by the other scales. Building convergent validities
therefore is well founded. Empirically, DCS was as little related to
the other patient administered measures as they were to each
other.
Results in context
Other studies support our findings of inconsistency within SDM
as measured from different perspectives. In a study of 212 doctor–
patient consultations in general. practice, there was only moderate
agreement between patient perceptions of their level of involve-
ment in decision making and the objective ratings using the
Figure 2. Relationship of OPTION and SDM-Q. Each point represents one consultation. Data are given separately for physicians 1 to 3 and for
the whole sample (physician 1: n=36, physician 2: n=23, physician 3: n=14, physician 4 n=3). Correlations are indicated by Spearman’s rho.
doi:10.1371/journal.pone.0026255.g002
Study on Interrelatedness of SDM Measures
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study of the Rochester Participatory Decision Making Scale,
objective behaviour of general practitioners was only weakly
correlated with simulated patients’ views on ‘‘health climate’’ and
‘‘physician trust’’ and largely uncorrelated with ‘‘finding common
ground’’ [28]. From the present study we cannot report data about
the congruency of physicians’ and observers’ perspectives or of
physicians’ and patients’ perspectives. However, it is known that
patients and physicians often have disparate experiences regarding
their encounters [29,31,34–37]. It has even been shown that the
parties’ perceptions of the physicians’ efforts to involve patients
can be diametrically opposed to one another. Paradoxically,
sometimes the fewer options offered to the patients, the more they
feel involved in the decision making process [30]. Patients lose
trust in physicians verbally expressing uncertainty [38–39]. The
phenomenon of discordance appears even within the same
perspective: In accordance with the present study discrepant
assessments of the same decision-making situation by the same
patients using different measures have already been shown by
others [25,40–41].
Our results touch some basic questions of SDM research with
far-reaching implications regarding methods and concept:
Implications
The relevance of the measurement perspective. The
results show that existing SDM instruments are not measuring the
same construct. This finding is disconcerting with regard to
assumptions that are apparently commonly made when these
measures are used, or the results they generate are reported. In
particular, at least SDMQ and OPTION explicitly refer to the
same construct, that is the ‘‘extent of patient involvement in the
process of decision making’’ [11,15]. With respect to face validity
and by partly using similar items, DCS and CPSpost seem to
address a similar definition of the SDM core-construct. This raises
the question as to who has the valid perspective: The observer,
who is independent of the event and therefore should be a reliable
source?; The physician, who is more or less biased by interfering
constructs and interests?; or the patient, who is-after all-the main
protagonist, but is nevertheless unaware of the criteria of evidence-
based patient information and shared decision making?
Considerations regarding construct and concept
Apart from the problem of the valid perspective, our result may
reflect conceptual deficits in SDM. Systematic consideration of the
existing definitions of SDM reveals widespread use of the term
although a clear and operational basic definition has not yet been
agreed [42–43]. There is also evidence supporting suggestions that
patients do not want to be involved along the academic taxonomies.
Patients’ conceptualisation of patient involvement contrasts the
emphasis within the dominant scientific discourse about patient
involvement [44]. As considered by patients in addition to the more
readily observable aspects of action and information exchange,
involvement does have a relational dimension perceived by patients
via more subtle qualities such as the tone or manner of doctors’
communication mediating caring, concern, respect and compassion
[9,44]. It has also been shown that patients tend to understand the
concept of participation in the process of making a decision in terms
of being involved with the doctor in a relational sense [45].
However, these patient-sided concepts of involvement can doubt-
lessly be properties of a paternalistic communication style as well.
Figure 3. Relationship of OPTION and DCS. Each point represents one consultation. Data are given separately for physicians 1 to 3 and for the
whole sample (physician 1: n=36, physician 2: n=23, physician 3: n=14, physician 4 n=3). Correlations are indicated by Spearman’s rho.
doi:10.1371/journal.pone.0026255.g003
Table 2. Pair-wise item level correlations of observers’ and patients’ views.
SDM issue SDM-Q item number OPTION item number Spearman’s rho p-value
opportunity to ask questions 2 9 2.04 .77
consideration of pros and cons 6 5 2.06 .62
follow up arrangement 10 / 11 12 .06 / .04 .63 / .79
Item pairs with identical semantic were selected.
doi:10.1371/journal.pone.0026255.t002
Study on Interrelatedness of SDM Measures
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mous patients may, on the other hand, even be seen as associated
with more social distance within the dyad [46].
Against this background, our results could highlight some
unwanted side effects of SDM communication techniques.
Incorporation of these conceptual considerations even seems to
complicate attempts to agree on a SDM core construct and to
assess the extent or quality of patient involvement. We therefore
want to draw the readers’ attention to a hitherto mostly neglected
character of SDM.
Intersubjectivity
As interaction is more than just two person’s actions,
involvement is an interpersonal event to be considered on an
intersubjective level. A key role of intersubjectivity in SDM as
claimed by some authors [13,47–48] is in line with its basic
definition as a ‘‘two-way exchange of information’’ [3] and would
imply that, finally, no single perspective could ever indicate SDM.
Therefore, lacking correspondence between unilateral SDM
measures might just result from the fact that taking each of the
measures separately, none of them is touching the intersubjective
quality of the construct. Moreover, phenomena of disagreement in
the appraisal of a communication, as discovered by this and other
studies, might, rather than an error of measurement, be highly
critical for the quality of communication in terms of SDM. Instead
of trying to avoid disagreement, this assumption would imply a
need to address interpersonal disagreement by measurements.
Therefore, attention to both participants’ as well as observers’
perspectives is needed to allow for analyses on a dyadic or triadic
data level [20,49–51].
Conclusion
The study casts a critical light on current SDM research by
indicating substantial limitations regarding the validity of existing
SDM measures with substantial implications for the interpretation
of SDM efficacy studies. Deeper analysis of the methods of
measurement also revealed weaknesses in the definitions of SDM.
However, inconsistencies between SDM measures and potential
interference of subjective and theoretical concepts of communica-
tion quality can inform a better understanding of the intersubjec-
tive core of the SDM concept. This concept can be better
enunciated using more sophisticated strategies to investigate
communication, such as dyadic analysis [49–51].
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